PRODUCT EVIDENCE JOURNAL · 08 / 10
Aqua Peeling Serum: an elbow result is not a whole-face promise
The tested body site and the measured surface feature change what a percentage can honestly mean.
NARINFLA JOURNAL · PRODUCT EVIDENCE SERIES

Official product photograph; not a study image.
On this page
Where were the two reported outcomes measured?What does a single-use result tell us?Do surface changes establish hydration or barrier repair?Is the skin-tolerance study the same evidence?What should an honest product explanation include?- The two 2025 ProBM reports each describe a single-use assessment in 20 women, with separate elbow and forehead endpoints.
- The reported mean changes were 98.5% in an elbow dead-skin metric and 69.1% in a forehead sebum metric.
- Those endpoints do not establish a whole-face exfoliation rate, lasting hydration, barrier repair or improved absorption of another product.
Where were the two reported outcomes measured?
Elbow: dead-skin metric
PM-25M09-SK021
Forehead: sebum metric
PM-25M09-SE018
Separate reports · each 20 women · one use · immediate and temporary · PM-25SA-531
The dead-skin outcome was measured on the elbow, while the sebum outcome was measured on the forehead. The body site is part of the evidence, not an optional detail that can be removed to make the claim sound broader.
The 2025 ProBM reports PM-25M09-SK021 and PM-25M09-SE018 each describe a single-use assessment in 20 women using sample PM-25SA-531. The reported immediate, temporary mean changes were 98.5% in the elbow dead-skin metric and 69.1% in the forehead sebum metric, respectively.
A chart reading “98.5% of facial dead skin removed” would therefore go beyond the information supplied. So would a claim that the entire face lost 69.1% of its oil. The study describes particular measurements at particular sites.
What does a single-use result tell us?
It tells us about the recorded immediate observation under the test conditions, not the lasting condition of the skin. We describe these as single-use, temporary surface changes rather than a permanent reset.
The percentage does not tell us how the measurement behaves after a week, whether the same change occurs with every repeated use or how long it persists. Those questions need additional observations and a suitable protocol.
It also does not prescribe how often you should use the serum. The product directions determine use; a high test percentage is not a reason to repeat application or increase friction in an attempt to recreate the laboratory result.
A reported surface measurement at the elbow after one use; not a universal facial exfoliation percentage.
A reported oil-related measurement at the forehead after one use; not a whole-face hydration or barrier measurement.
Related evidence: Reading the 3F numbers: the average is not the best individual result. Official product ingredients and study information.
Do surface changes establish hydration or barrier repair?
No. Dead-skin and sebum endpoints are not direct substitutes for hydration or barrier measurements. A skin-surface result can be relevant to a peeling product without answering every question about moisture or sensitivity.
Nor does it show that a later ampoule penetrates more deeply or works better. To establish an additional effect from the combination, a relevant study would need to examine that combination rather than rely on two separate product reports.
We therefore avoid the phrase “opens the path for other actives” as a conclusion from these numbers. It is a mechanistic and combination-use claim that the reported elbow and forehead endpoints do not establish.
Is the skin-tolerance study the same evidence?
No. The separate 30-person patch assessment concerns tolerability under its own conditions. It does not replace the 20-person efficacy study, and the efficacy percentages are not evidence that irritation is impossible.
This distinction matters for sensitive or recently treated skin. A favorable tolerability result does not establish pregnancy safety, suitability after a laser procedure or compatibility with microneedling and every exfoliating routine.
Similarly, visible residue during application should not automatically be described as dead skin. Unless the material has been identified, appearance alone cannot establish what it contains or how much of the measured change it represents.
What should an honest product explanation include?
Keep the evidence in its own lane
A group result is not a guarantee for an individual.
A measurement applies to its stated sample, conditions and period.
A separate-product study is not a test of a combined routine.
It should include the product, measured site, endpoint, participant count, institution and single-use timing together. For Aqua Peeling Serum, the elbow and forehead conditions belong in the main explanation, not hidden beneath a general facial promise.
A truthful illustration can mark the two tested sites and explain their different measurements. It should not turn a diagram into a fabricated patient before-and-after image or depict a skin barrier being repaired without the corresponding evidence.
For actual use, follow the label and stop if irritation occurs. Do not transfer the test’s body-site conditions into an improvised home protocol, and do not assume that a larger dose or more frequent use gives a larger benefit.
The narrower conclusion is still useful: two specified, temporary surface observations after one use. Keeping the claim at that scale makes the information clearer without asking the study to answer questions it did not test.
Questions & answers
Can I call 98.5% the facial exfoliation rate?
No. That rounded value refers to the elbow dead-skin metric in the single-use study, not the entire face.
Does 69.1% prove the skin became more hydrated?
No. It refers to the forehead sebum metric. Hydration and barrier performance require appropriate separate evidence.
Can the elbow and forehead results become one whole-face claim?
No. The separate reports concern an elbow dead-skin metric and a forehead sebum metric after one use. They do not establish a whole-face or long-term result.
Sources and scope
- ProBM Aqua Peeling Serum surface-condition study, 2025
Separate brand-held reports PM-25M09-SK021 (elbow dead skin) and PM-25M09-SE018 (forehead sebum), sample PM-25SA-531; each reports a single-use assessment in 20 women, not general whole-face or long-term barrier outcomes.
- Technical document on cosmetic claims, Claims Sub-Working Group, 3 July 2017, Annexes I–II
Non-binding best-practice guidance on relevant evidence, product identity, study conditions and avoiding exaggerated interpretations; not a narinfla trial or European Commission legal ruling.
- narinfla official English product information
Official brand hub; consult the corrected version for product-specific information. Not a public archive of the full clinical reports.
Related reading
Read the official product facts →Information only. Follow the current package directions. Cosmetics do not replace diagnosis or treatment.